FE

Fermi Inc.

FRMI | US

Overview

Corporate Details

ISIN(s):
US3149111086
LEI:
529900TSHBYBCFMYZ228
Country:
United States of America
Address:
N/A
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

No description available.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-01 13:10
Environmental & Social Information
Fermi and MVM EGI Announce Hybrid Cooling MOU
English 13.9 KB
2025-11-25 08:20
Capital/Financing Update
Response to Speculation
English 10.1 KB
2025-11-13 08:25
Report Publication Announcement
Publication of Fermi Inc. Interim Financial Report
English 10.3 KB
2025-11-11 08:25
Report Publication Announcement
Fermi Posts Third Quarter 2025 Shareholder Letter
English 13.6 KB
2025-11-06 08:25
Regulatory Filings
Advance in Aid of Construction Agreement
English 10.3 KB
2025-11-05 08:25
Report Publication Announcement
Notice of Inaugural Earnings Call
English 13.9 KB
2025-11-04 08:30
Environmental & Social Information
State of Texas Preliminary Approval for First 6GW
English 19.6 KB
2025-10-30 08:00
Regulatory Filings
Partnerships Announcement
English 14.9 KB

Automate Your Workflow. Get a real-time feed of all Fermi Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Fermi Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Fermi Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Rafael Holdings, Inc. Logo
Invests in and develops novel therapeutics for cancer and rare diseases.
United States of America
RFL
Rain Enhancement Technologies Holdco, Inc. Logo
Develops ionization tech to generate rain and mitigate fog for water-scarce regions.
United States of America
RAIN
Rallybio Corp Logo
Develops therapies for severe and rare diseases in hematology and complement dysregulation.
United States of America
RLYB
RaQualia Pharma Inc. Logo
An R&D firm discovering novel small molecules for out-licensing to pharma partners.
Japan
4579
RECURSION PHARMACEUTICALS, INC. Logo
AI-driven biotech accelerating drug discovery for rare diseases and oncology.
United States of America
RXRX
RELMADA THERAPEUTICS, INC. Logo
A clinical-stage biotech developing novel therapies for CNS diseases and oncology.
United States of America
RLMD
RenovoRx, Inc. Logo
Develops a device platform for delivering targeted therapies directly to solid tumors.
United States of America
RNXT
Repare Therapeutics Inc. Logo
Develops precision oncology drugs using a CRISPR platform for cancers with genomic instabilities.
United States of America
RPTX
Replimune Group, Inc. Logo
Clinical-stage biotech developing oncolytic immunotherapies to treat a broad range of cancers.
United States of America
REPL
ReproCELL Incorporated Logo
Offers stem cell tech, gene editing & drug discovery services for preclinical/clinical research.
Japan
4978

Talk to a Data Expert

Have a question? We'll get back to you promptly.